Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hemodilution and coagulation. An overview.

P Hobisch-Hagen1

  • 1Clinic of Anesthesia and General Intensive Care Medicine, University of Innsbruck, Austria. Petra.Hobisch-Hagen@uibk.ac.at

Minerva Anestesiologica
|May 25, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Clinical relevance of immunomodulation after blood transfusion in non-oncologic patients].

Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS·2002
Same author

Blunted erythropoietic response to anemia in multiply traumatized patients.

Critical care medicine·2001
Same author

Low platelet count and elevated serum thrombopoietin after severe trauma.

European journal of haematology·2000
Same author

Immunologic changes after transfusion of autologous or allogeneic buffy coat-poor versus WBC-reduced blood transfusions in patients undergoing arthroplasty. II. Activation of T cells, macrophages, and cell-mediated lympholysis.

Transfusion·2000
Same author

Increase in immune activation, vascular endothelial growth factor and erythropoietin after an ultramarathon run at moderate altitude.

Immunobiology·2000
Same author

Immunologic changes after transfusion of autologous or allogeneic buffy coat-poor versus white cell-reduced blood to patients undergoing arthroplasty. I. Proliferative T-cell responses and the balance of helper and suppressor T cells.

Transfusion·1999

Perioperative hemodilution can negatively impact blood clotting (hemostasis). Artificial colloids, in particular, may worsen bleeding risks in patients with underlying platelet disorders like von Willebrand disease.

Area of Science:

  • Anesthesiology
  • Hematology
  • Pharmacology

Background:

  • Perioperative hemodilution is a common practice involving fluid administration during surgery.
  • Maintaining hemostasis is critical for patient safety and surgical outcomes.
  • Artificial colloids are frequently used for volume expansion but their effects on hemostasis require careful consideration.

Purpose of the Study:

  • To review the adverse effects of perioperative hemodilution.
  • To specifically examine how hemodilution modulates hemostasis.
  • To highlight the impact of artificial colloids on hemostasis, particularly in vulnerable patient populations.

Main Methods:

  • Literature review of relevant medical studies.
  • Analysis of adverse effects associated with perioperative fluid management.

Related Experiment Videos

  • Focus on the interaction between artificial colloids and hemostatic function.

    • Main Results:

    • Artificial colloids demonstrate a specific mechanism of impairing hemostasis.
    • This impairment is more pronounced in patients with pre-existing platelet function abnormalities.
    • Mild forms of von Willebrand disease represent a specific risk group.

    Conclusions:

    • Artificial colloids can significantly disrupt normal hemostasis.
    • Patients with congenital platelet disorders are at increased risk of bleeding complications when administered artificial colloids.
    • Careful patient selection and monitoring are essential when using artificial colloids in the perioperative setting.